Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
HCAT 
Health Catalyst Inc (HCAT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: HCAT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $3.94
1 Year Target Price $3.94
| 7 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.35% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 173.29M USD | Price to earnings Ratio - | 1Y Target Price 3.94 |
Price to earnings Ratio - | 1Y Target Price 3.94 | ||
Volume (30-day avg) 13 | Beta 1.7 | 52 Weeks Range 2.02 - 7.20 | Updated Date 01/9/2026 |
52 Weeks Range 2.02 - 7.20 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.58 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.05% | Operating Margin (TTM) -10.03% |
Management Effectiveness
Return on Assets (TTM) -4.74% | Return on Equity (TTM) -31.33% |
Valuation
Trailing PE - | Forward PE 11.67 | Enterprise Value 253869665 | Price to Sales(TTM) 0.55 |
Enterprise Value 253869665 | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 0.8 | Enterprise Value to EBITDA -4.96 | Shares Outstanding 70730884 | Shares Floating 59907644 |
Shares Outstanding 70730884 | Shares Floating 59907644 | ||
Percent Insiders 10.1 | Percent Institutions 78.99 |
Upturn AI SWOT
Health Catalyst Inc
Company Overview
History and Background
Health Catalyst Inc. was founded in 2008 with a mission to improve healthcare outcomes and reduce costs through data and analytics. The company has experienced significant growth, evolving from a startup to a publicly traded entity. Key milestones include securing substantial funding rounds and launching its comprehensive data platform. Over time, Health Catalyst has expanded its product offerings and customer base, solidifying its position in the healthcare technology market.
Core Business Areas
- Data and Analytics Platform: Health Catalyst's core offering is its cloud-based data and analytics platform that integrates data from disparate sources within healthcare organizations. This platform enables healthcare providers to gain insights into clinical, financial, and operational performance.
- Solutions: The company offers a suite of targeted solutions built on its platform, addressing specific healthcare challenges such as population health management, care management, revenue cycle management, and quality improvement.
- Services: Health Catalyst also provides professional and managed services to assist clients with data integration, implementation, and ongoing support, ensuring effective utilization of their platform and solutions.
Leadership and Structure
Health Catalyst Inc. is led by a management team with extensive experience in healthcare and technology. The organizational structure is designed to support product development, sales, customer success, and professional services. Key leadership roles include CEO, COO, CFO, and heads of various divisions.
Top Products and Market Share
Key Offerings
- Product Name 1: Health Catalyst Data Operating System (DOSu2122) - A comprehensive data platform that provides a unified view of healthcare data. Competitors include Snowflake, Databricks, and other enterprise data warehousing solutions adapted for healthcare. Specific market share data for this platform is not publicly disclosed, but it is the foundation for their solutions.
- Product Name 2: Population Health Management Solutions - Tools and analytics designed to identify at-risk patient populations, manage chronic diseases, and improve outcomes. Competitors include Optum, Cerner, and various specialized population health vendors. Market share is fragmented but growing.
- Product Name 3: Quality and Patient Safety Solutions - Offerings focused on improving clinical quality metrics, reducing adverse events, and enhancing patient safety. Competitors include Press Ganey, Vizient, and other quality improvement vendors. Market share is significant within the specific use cases.
Market Dynamics
Industry Overview
The healthcare analytics and data management industry is experiencing rapid growth, driven by the increasing volume of healthcare data, the demand for improved patient outcomes, cost containment pressures, and regulatory requirements. The shift towards value-based care necessitates robust data capabilities.
Positioning
Health Catalyst is positioned as a leading provider of data and analytics solutions for healthcare organizations. Its competitive advantages lie in its integrated platform approach, deep healthcare domain expertise, and a focus on delivering measurable outcomes for its clients. They aim to be a strategic partner in transforming healthcare operations through data.
Total Addressable Market (TAM)
The TAM for healthcare analytics and data management is substantial and growing. While specific TAM figures vary by research firm, it is estimated to be in the tens of billions of dollars globally. Health Catalyst is targeting a significant portion of this market, particularly in the US, focusing on health systems and providers looking to leverage their data.
Upturn SWOT Analysis
Strengths
- Integrated data platform providing a single source of truth.
- Deep healthcare domain expertise and understanding of clinical workflows.
- Focus on delivering measurable outcomes and ROI for clients.
- Strong customer relationships and high retention rates.
- Scalable cloud-based architecture.
Weaknesses
- Relatively smaller market share compared to some larger, more established players.
- Dependence on the successful integration of complex healthcare data systems.
- Potential for long sales cycles and implementation timelines.
- Competition from larger, diversified healthcare IT vendors.
Opportunities
- Growing demand for AI and machine learning in healthcare analytics.
- Expansion into new healthcare verticals and international markets.
- Partnerships with EHR vendors and other healthcare technology providers.
- Increased focus on interoperability and data sharing.
- Leveraging data for personalized medicine and preventative care.
Threats
- Intense competition from existing and new market entrants.
- Changes in healthcare regulations and reimbursement policies.
- Cybersecurity threats and data privacy concerns.
- Economic downturns impacting healthcare IT spending.
- Rapid technological advancements requiring continuous innovation.
Competitors and Market Share
Key Competitors
- Epic Systems (Private)
- Cerner (now Oracle Health)
- Allscripts (now Veradigm)
- Optum (UnitedHealth Group)
- Microsoft (via Nuance acquisition and Azure healthcare offerings)
Competitive Landscape
Health Catalyst differentiates itself through its specialized healthcare data platform and solutions, focusing on actionable insights rather than just data storage. While larger competitors have broader offerings, Health Catalyst's expertise in data analytics and its tailored solutions for specific healthcare challenges are key advantages. However, the market is highly competitive with significant resources at play from large technology and healthcare conglomerates.
Major Acquisitions
Syntellis Performance Solutions
- Year: 2024
- Acquisition Price (USD millions): 1175
- Strategic Rationale: To expand its financial analytics capabilities and address the growing demand for comprehensive enterprise performance management solutions in healthcare.
i2i Systems, Inc.
- Year: 2022
- Acquisition Price (USD millions): 90
- Strategic Rationale: To enhance its capabilities in providing data and analytics solutions to smaller and mid-sized hospitals and health systems, broadening its market reach.
Growth Trajectory and Initiatives
Historical Growth: Health Catalyst has demonstrated a history of strong revenue growth, fueled by its expanding customer base and product portfolio. The company has transitioned from a private entity to a public one, indicating a growth-oriented strategy.
Future Projections: Future growth is projected to be driven by the continued adoption of its data platform and solutions, expansion into new markets, and potential acquisitions. Analyst estimates for future revenue and earnings per share can be found in financial research reports.
Recent Initiatives: Recent initiatives may include the launch of new AI-powered analytics capabilities, strategic partnerships to enhance data interoperability, and expansion of their professional services offerings to support broader digital transformation in healthcare.
Summary
Health Catalyst Inc. is a significant player in the healthcare analytics market, offering a robust data platform and specialized solutions. Its strengths lie in its deep industry expertise and focus on measurable outcomes. However, the company faces intense competition and must continually innovate to maintain its edge. Future growth will depend on its ability to expand its market share and navigate the evolving healthcare technology landscape effectively.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Health Catalyst Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Financial News Outlets (e.g., Bloomberg, Reuters)
- Industry Analyst Reports
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Financial data and market share estimates are subject to change and may vary depending on the source and methodology. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Health Catalyst Inc
Exchange NASDAQ | Headquaters South Jordan, UT, United States | ||
IPO Launch date 2019-07-25 | CEO & Director Mr. Daniel D. Burton | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1500 | Website https://www.healthcatalyst.com |
Full time employees 1500 | Website https://www.healthcatalyst.com | ||
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.